PADI4 and type 2 diabetes mellitus: To determine the role of NETosis in this process, we performed pharmacological inhibition of NETosis with the peptidyl arginine deiminase 4 inhibitor (PAD4i) GSK484 in db/db mice with 6 months of type 2 diabetes.